STOCKHOLM, Sweden, April 7, 2009 (GLOBE NEWSWIRE) -- Diamyd Medical is announcing today that the company’s two principal owners, Bertil Lindquist and Anders Essen-Moller, is each converting 10,000 Diamyd TO 2B warrants into shares in Diamyd Medical AB. The exercise price is SEK 100 per share.
